Conference abstractPublished 2 Oct 2017
PELE Studio: the next generation drug design software
Barcelona Supercomputing Center, Spain
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
We are clearly assisting a rise of computational predictions in drug design; top pharmaceutical companies are signing large contracts with modeling software companies. This, has been made possible by the improvement in the techniques (algorithms) but also by the rise in computational power, such as the use of graphic processing units (GPUs) in molecular dynamics of docking program. Next generation drug design software, however, will embrace additional (current) technological developments. In this line we are combining PELE, our Monte Carlo sampling technique highlighted as an outstunding achievement in the latest CSAR blind test, with machine learning algorithms, high performance computing and improved 2D/3D visualization techniques. Our aim is to provide a drug design software capable of: i) INTERACTIVE, instantaneous answers; ii) ACCURATE, quantitative answers; iii) SMART: self-learining capabilities; iv) CONNECTING: providing a virtual working space. Our efforts and initial results in this line will be provided in this talk.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectComputer Science & IT
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Victor Guallar”
